Derivative exercise or conversion — not an open-market buy.
Traded Sep 30, 2026 · Filed Oct 3, 2026
A board member of Doximity sold $34K of Doximity shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$34,456
Shares × reported transaction price
55 days after results of Aug 6, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $28.34 on Sep 30, 2026, 57% above its 52-week low and 61% below its high, after a 14% rise over the previous 30 trading days
52-week range $18.01 (May 14, 2026) to $73.53 (Oct 8, 2025), 19% of the way up, from 248 adjusted closes. 30 trading days earlier: $24.94 on Aug 18, 2026. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
Derivative exercise or conversion — not an open-market buy.
Director sold ~$58K of Doximity
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.